Quality of treatment for lung cancer varies widely across US

byWashington University in St. LouisA new study by researchers at Washington University School of Medicine in St. Louis found that the quality of care for lung cancer in the U.S. varies widely.

Updated on: December 28,2023

Quality of treatment for lung cancer varies widely across US

byWashington University in St. LouisA new study by researchers at Washington University School of Medicine in St. Louis found that the quality of care for lung cancer in the U.S. varies widely.

Updated on:December 28,2023

FDA Approves Two Cell-Based SCD Gene Therapies

February 2024The U.S. Food and Drug Administration (FDA) approved exagamglogene autotemcel (exa-cel) and lovotibeglogene autotemcel (lovo-cel) for the treatment of sickle cell disease (SCD) in patient

Updated on: February 18,2024

FDA Approves Two Cell-Based SCD Gene Therapies

February 2024The U.S. Food and Drug Administration (FDA) approved exagamglogene autotemcel (exa-cel) and lovotibeglogene autotemcel (lovo-cel) for the treatment of sickle cell disease (SCD) in patient

Updated on:February 18,2024

Prolonging the survival of patients with gastric cancer

by Anne Grimm,Leipzig UniversityCredit: Unsplash/CC0 Public DomainGastric cancer is the fifth most commonly diagnosed malignancy worldwide. It ranks a sad third in cancer-related causes of death

Updated on: January 16,2024

Prolonging the survival of patients with gastric cancer

by Anne Grimm,Leipzig UniversityCredit: Unsplash/CC0 Public DomainGastric cancer is the fifth most commonly diagnosed malignancy worldwide. It ranks a sad third in cancer-related causes of death

Updated on:January 16,2024

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

by University of SouthamptonMammograms showing a normal breast (left) and a cancerous breast (right). Credit: Wikipedia.A new study led by scientists at the University of Southampton has found th

Updated on: March 01,2024

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

by University of SouthamptonMammograms showing a normal breast (left) and a cancerous breast (right). Credit: Wikipedia.A new study led by scientists at the University of Southampton has found th

Updated on:March 01,2024

Editorial: Genotype matters—tailored screening for germline CHEK2 variants

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA recent editorial was published inOncotarget, titled "Genotype matters: Personalized screening recommendations for germline CHEK2 var

Updated on: September 07,2024

Editorial: Genotype matters—tailored screening for germline CHEK2 variants

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA recent editorial was published inOncotarget, titled "Genotype matters: Personalized screening recommendations for germline CHEK2 var

Updated on:September 07,2024

Genetically engineered dendritic cells enhance the power of immunotherapy against lung cancer

by Denise Heady,University of California, Los AngelesGraphical Abstract. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2024.101479A study by researchers at the UCLA Health

Updated on: March 30,2024

Genetically engineered dendritic cells enhance the power of immunotherapy against lung cancer

by Denise Heady,University of California, Los AngelesGraphical Abstract. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2024.101479A study by researchers at the UCLA Health

Updated on:March 30,2024

Survey finds one in three patients needed more information on cancer treatment side effects

by American Society for Radiation OncologyIn a nationwide survey of US adults treated for cancer, 1 in 3 patients said they experienced side effects from cancer treatment that they wish they'

Updated on: March 06,2024

Survey finds one in three patients needed more information on cancer treatment side effects

by American Society for Radiation OncologyIn a nationwide survey of US adults treated for cancer, 1 in 3 patients said they experienced side effects from cancer treatment that they wish they'

Updated on:March 06,2024

Breakthrough brings potential glioblastoma drug into focus

byKeck School of Medicine of USCA new type of small molecule drug, the first to target circadian clock proteins as a way to treat glioblastoma, is now in phase 1 clinical trials. Credit: Issey T

Updated on: January 07,2024

Breakthrough brings potential glioblastoma drug into focus

byKeck School of Medicine of USCA new type of small molecule drug, the first to target circadian clock proteins as a way to treat glioblastoma, is now in phase 1 clinical trials. Credit: Issey T

Updated on:January 07,2024

Stopping the resistance of cancer cells to treatment

by Colin Poitras,University of ConnecticutCredit: CC0 Public DomainOne of the drawbacks of chemotherapy is that cancer patients can build up resistance to treatment over time, increasing their c

Updated on: April 01,2024

Stopping the resistance of cancer cells to treatment

by Colin Poitras,University of ConnecticutCredit: CC0 Public DomainOne of the drawbacks of chemotherapy is that cancer patients can build up resistance to treatment over time, increasing their c

Updated on:April 01,2024

Travel time for breast cancer screening remains long for many women in the US, new study shows

by American Cancer SocietyA new study led by researchers at the American Cancer Society shows travel time to the nearest mammography facility is long for a considerable proportion of women in the

Updated on: February 20,2024

Travel time for breast cancer screening remains long for many women in the US, new study shows

by American Cancer SocietyA new study led by researchers at the American Cancer Society shows travel time to the nearest mammography facility is long for a considerable proportion of women in the

Updated on:February 20,2024

RNA-based therapy shows promise against aggressive childhood brain tumors in mice

by Johns Hopkins UniversityCredit:Cell Reports(2024). DOI: 10.1016/j.celrep.2024.113938Targeting a non-encoding stretch of RNA may help shrink tumors caused by an aggressive type of b

Updated on: March 20,2024

RNA-based therapy shows promise against aggressive childhood brain tumors in mice

by Johns Hopkins UniversityCredit:Cell Reports(2024). DOI: 10.1016/j.celrep.2024.113938Targeting a non-encoding stretch of RNA may help shrink tumors caused by an aggressive type of b

Updated on:March 20,2024

Research: Subset of breast cancers have two PIK3CA mutations on the same allele

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA team of researchers affiliated with a large number of institutions in the U.S. has found that a subgroup of breast cancers have two PIK3CA mutat

Updated on: June 01,2024

Research: Subset of breast cancers have two PIK3CA mutations on the same allele

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA team of researchers affiliated with a large number of institutions in the U.S. has found that a subgroup of breast cancers have two PIK3CA mutat

Updated on:June 01,2024